Tag: #veronapharma

Merck & Co. to Acquire Verona Pharma for $10 Billion, Boosting Respiratory Portfolio

Merck acquires Verona Pharma for $10B, enhancing its COPD treatment offerings with the novel drug Ohtuvayre.

#merck, #veronapharma, #acquisition, #copd, #pharma

Merck Acquires Verona Pharma in $10 Billion Deal to Boost Respiratory Portfolio

Merck's $10 billion acquisition of Verona Pharma enhances its respiratory market presence. Ohtuvayre, a novel COPD drug, is central to the deal.

#merck, #veronapharma, #acquisition, #respiratory, #pharmaceuticals

Merck Acquires Verona Pharma for $10 Billion to Expand Respiratory Treatments

Merck & Co. will acquire Verona Pharma for $10 billion to strengthen its respiratory treatment portfolio with innovative COPD therapy.

#merck, #veronapharma, #acquisition, #healthcare, #respiratorydisease

Merck Acquires Verona Pharma for $10 Billion to Boost Respiratory Portfolio

Merck acquires UK-based Verona Pharma for $10B, enhancing its respiratory treatments ahead of Keytruda's 2028 patent expiration.

#merck, #veronapharma, #acquisition, #pharmaceuticals, #respiratorydisease